NIGELLA SATIVA CONCOCTION INDUCED SUSTAINED SEROREVERSION IN HIV PATIENT

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 10, Issue 5, 2013, Pages 332-335

  Onifade, Abdulfatah Adekunle ^a   Jewell, Andrew Paul ^b   Adedeji, Waheed Adeola ^c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

HIV infection; Nigella sativa; sero reversion

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PLANT MEDICINAL PRODUCT;

ARTICLE; BLACK CUMIN; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PHYTOTHERAPY; REMISSION; SERO-REVERSION; VIROLOGY; VIRUS LOAD;

HIV INFECTION; NIGELLA SATIVA; SERO-REVERSION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NIGELLA SATIVA; PHYTOTHERAPY; PLANT PREPARATIONS; REMISSION INDUCTION; VIRAL LOAD;

EID: 84904843493     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v10i5.18     Document Type: Article

References (30)

1. Abbas AK, Lichtman AH & Pober JS (2000). Cellular and molecular immunology, Philadelphia USA (4th edition) pages 445-467.
2. Ahmed IH, Awad MA, El-Mahdy M, Gohar HM, Ghanem AM (1995). The effect of some medicinal plant extracts on wound healing in farm animals. Assiut Veterinary Medical Journal, 32 (64):236–44.
3. Akhtar MS, Riffat S (1991). Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J Pakistan Med Assoc, 41(8):185–7.
4. Al-Bukhari. MI (1976). Division (71) on medicine, In Sahi Al-Bukhari, the collection of authentic sayings of Prophet Mohammad (Peace be upon him). 2nd ed. Hilal Yayinlari, Ankara, Turkey, 1976.
5. Al-Ghamdi MS (2001). Anti-inflammatory, analgesic and anti-pyretic activity of Nigella sativa, J. Ethnopharmacol, 76:45–8.
6. Aljabre SHM, Randhawa MA, Akhtar A, Alakloby OM, Alqurashi AM and Aldossary A (2005). Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J. Ethnopharmacology, 101(1– 3):116–9
7. Badar El-Din MK (1960). Anti-asthmatic activity of the active principle of Nigella sativa “Nigellone” Gazette Egypt Paediatr Assoc, 8(4):864–7
8. Bamosa AO, Ali BA, Sowayan SA (1997). Effect of oral ingestion of Nigella sativa seed on some blood parameters, Saudi Pharm J, 5(2–3):126–9
9. Cos P, Maes L, Vlientinck A and Pieters L (2008). Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection-an update (1998-2007), Planta Med 74; 1323-1337
10. Coyne KM, Parry JV, Atkins M, Pozniak A, and McOwan A (2007). “Spontaneous HIV-1 seroreversion in an adult male,” Sexually Transmitted Diseases, 34 (9) 627–630
11. Dhamaratne HRW, Tan GT, Marasinghe GPK, Pezzuto JM (2002). Inhibition of HIV-1 reverse transcriptase and HIV-1replicationby Calophyllum coumarins and xanthones, Planta Med; 68: 86–87.
12. El-Kadi A, Kandil O (1986). Effect of Nigella sativa (the black seed) on immunity, Proceeding of the 4th International Conference on Islamic Medicine, Kuwait. Bull Islamic Med, 4:344–8.
13. Finzi D and Siliciano RF (1998). Viral dynamics in HIV-infection, Cell 93:665-671
14. Houghton PJ, Zarka R, de las Heras B, Hoult JR (1995). Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med, 61(1):33– 6
15. Hütter G, Nowak D, Mossner M, Ganepola S, Ganepola A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E (2009). "Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation". N Engl J Med 360 (7): 692–698
16. Isaiah 28: 25, 27
17. Jurriaans S, Sankatsing SU, Prins JM, Schuitemaker H, Lange J, Van Der Kuyl AC, Cornelissen M (2004). HIV-1 seroreversion in an HIV-1 seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil, AIDS:18 (11) 1607-8
18. Kassutto S, Johnston MN and Rosenberg ES (2005).“Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy,” Clinical Infectious Diseases, 40 (6) 868–873.
19. th edition, W H Freeman and Company New York (USA) Pages 504-520 ISBN 9780716767640.
20. Kong J M, Goh N K, Chia L S and Chia T F (2003). Recent advances in traditional plant drugs and orchids, Acta Pharmacol.Sin. 24, 7-21.
21. Levin A, Hayouka Z, Friedler A and Loyter A (2010). Specific eradication of HIV-1 from infected cultured cells, AIDS Research and Therapy 7:31 doi:10.1186/1742-6405-7-31.
22. Lu WB, Wen RX, and Guan CF (1997). “A report on 8 seronegative converted HIV/AIDS patients with traditional Chinese medicine,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi, 17 (5) 271– 273 (Chinese)
23. Matthee G, Wright AD, König G (1999). HIV reverse transcriptase inhibitors of natural origin, Planta Med; 65: 493–506
24. Morsi NM (2000). Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotic resistant bacteria. Acta Microbiol Pol, 49(1):63–74
25. Onifade AA, Jewell AP, Okesina AB, Ajadi TA, Rahamon SK, Muhibi MO (2012). 5 month therapy and complete sero-reversion with recovery in an adult HIV/AIDS patient, Scientific reports 124, 1 (1) 1-3, http://dx.doi.org/10.4172
26. Randhawa M A (2008). Black seed, Nigella sativa, deserves more attention, J Ayub Med Coll Abbottabad; 20 (2) http://www.ayubmed.edu.pk/JAMC/Past/20-2/Editorial.pdf 1
27. Topozada HH, Masloum H, El-Dakhakhany M (1965). The antibacterial properties of Nigella sativa seeds: Active principle with some clinical application. J Egypt Med Assoc, 48(suppl):187–202
28. Watson K, Gooderham NJ, Davies DS, Edwards RJ (1999). Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides, Biochem Pharmacol; 57: 775–783.
29. WHO (2002). Traditional Medicine; Growing Needs and Potential, WHO Policy Perspectives on Medicines. World Health Organization, Geneva; pp. 1–6
30. UNAIDS/WHO delete(2010). "UN Millenium Goals report 2010", pages 1-45.